Plain-English translation of NCT04615988 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is investigating a connection between vitamin D levels and thyroid complications in patients receiving immunotherapy drugs like nivolumab or pembrolizumab for cancer. These medications work by "releasing the brakes" on the immune system so it can fight tumors more effectively. However, sometimes this can cause the immune system to accidentally attack the body's own organs, including the thyroid.
Immunotherapy is an exciting cancer treatment, but it can sometimes trigger autoimmune side effects where the body attacks its own tissues. Researchers want to understand if vitamin D levels might play a role in protecting patients from these complications, which could eventually help doctors prevent or better manage these side effects.
You likely qualify if…
You likely don't qualify if…
As a participant, you would continue receiving your standard cancer immunotherapy treatment from your oncologist as planned. During the study, you would have blood drawn at multiple visits so researchers can measure your vitamin D levels and monitor your thyroid function. You would also complete short questionnaires about any symptoms you experience. The study involves no additional medications or procedures beyond what your doctor is already recommending for your cancer treatment.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States